Macau Casino Gambli...
Health Care: Drugs
Aastrom Biosciences Inc. (ASTM: NASDAQ)
$1.96 -0.03 | -1.51%
06/01/12 - 03:59 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Jun 2010 | Jun 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 5.53M | 31.25M | 14.12M | 17.00M |
| Receivables | 9.00K | 25.00K | 16.00K | 58.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 1.00K |
| Other Current Assets | 636.00K | 426.00K | 383.00K | 732.00K |
| Total Current Assets | 6.18M | 31.70M | 19.52M | 17.79M |
| Property, Plant & Equipment, Gross | 5.70M | 5.02M | 4.66M | 4.60M |
| Accumulated Depreciation & Depletion | 4.14M | 3.89M | 3.65M | 3.12M |
| Property, Plant & Equipment, Net | 1.56M | 1.13M | 1.01M | 1.48M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Assets | 1.56M | 1.13M | 1.01M | 1.48M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 7.74M | 32.83M | 20.53M | 19.28M |
| Accounts Payable | 2.24M | 2.90M | 1.75M | 853.00K |
| Short Term Debt | 40.00K | 214.00K | 226.00K | 479.00K |
| Other Current Liabilities | 16.62M | 25.95M | 0.00 | 0.00 |
| Total Current Liabilities | 20.67M | 29.86M | 2.66M | 1.69M |
| Long Term Debt | 40.00K | 41.00K | 79.00K | 305.00K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 40.00K | 41.00K | 79.00K | 305.00K |
| Total Liabilities | 20.71M | 29.90M | 2.74M | 1.99M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | -12.97M | 2.92M | 17.79M | 17.28M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 228.88M | 225.10M | 231.34M | 213.11M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -241.85M | -222.18M | -213.55M | -195.82M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | -12.93M | 2.96M | 17.87M | 17.59M |
| Total Equity | -12.97M | 2.92M | 17.79M | 17.28M |
| Total Liabilities & Stock Equity | 7.74M | 32.83M | 20.53M | 19.28M |
| Total Common Shares Outstanding | 38.64M | 38.62M | 28.26M | 21.47M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 38.63M | 29.19M | 24.73M | 17.88M |
| Diluted Weighted Shares Outstanding | 38.63M | 29.19M | 24.73M | 17.88M |
| Number of Employees | 71 | 54 | 45 | 48 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ASTM
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- Contributor10 Cheap Biotech Stocks Tha...
- Usermrtimrx WatchList
- UserMy Folly
- Userbosw119
- Usergellis1360 Portfolio 1
- UserSusu's Stocks
- UserRet2009
- Userspecialinterest
- Userpo boy
Latest ASTM Headlines from TheStreet
- Aastrom Raises Cash To Fund Pivotal Trial 03.09.12 | 12:03 pm
- More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More 02.29.12 | 07:02 am
- Aastrom CEO: Financing Close to Completion 01.18.12 | 08:01 am
- Aastrom Cell Therapy Reverses Effects of Blocked Leg Arteries 11.14.11 | 02:11 pm
- The Next Big Thing In Biotech: Aastrom
11.11.11 | 05:11 am - Biotech Calendar: Key Dates for November 11.01.11 | 10:11 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- Biotech Stock Mailbag: Live Chat 06.17.11 | 11:06 am
- Biotech Stock Mailbag: Aastrom BioSciences 06.03.11 | 06:06 am
Press Releases for ASTM
Partner Headlines for ASTM
- Follow the Analyst Leader: New Stock Coverage to Watch - Wall St. Cheat Sheet 05.31.12 | 04:05 am
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am
- Aastrom Biosciences Announces Initiation of Patient Enrollment in REVIVE Phase 3 Clinical Trial of Ixmyelocel-T - Benzinga 02.29.12 | 04:02 pm
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Aastrom Bio: Final RESTORE Data Looks Solid - Seeking Alpha 11.15.11 | 09:11 am
- 6 Recently Crushed Stocks With Heavy New Insider Buying - Seeking Alpha 08.14.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Aastrom Files At-the-Market Offering and New Shelf Registration Statement - Benzinga 06.16.11 | 04:06 pm
- Aastrom Biosciences' Trial Meets Safety and Efficacy Endpoints - Seeking Alpha 06.02.11 | 09:06 am
- 6 Speculative Biotech Stocks Smart Money Loves - Seeking Alpha 05.23.11 | 09:05 am
